Vital Images extends Toshiba agreement

Article

The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed

The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed the software since 2000 through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excluding Japan. The 3D medical imaging product is sold primarily as an adjunct to Toshiba's Aquilion and Asteon CT scanners. The new agreement includes a minimum worldwide revenue commitment from Toshiba of $7.7 million and is effective through Dec. 31, 2004. At the RSNA meeting, Vital Images demonstrated Vitrea version 3.4 offering enhanced 3D visualization and analysis tools, including automated tools for examining vasculature.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.